Coverage depends on your plan. A growing number of commercial (employer/marketplace) plans cover Zepbound for chronic weight management, but most require prior authorization and a qualifying BMI (typically ≥30, or ≥27 with a weight-related condition). Check your plan’s formulary and PA criteria.
Medicare does not cover GLP-1s for weight loss alone, but it can cover Zepbound for the FDA-approved obstructive-sleep-apnea indication. Medicaid coverage varies by state. If you are not covered, LillyDirect self-pay Zepbound vials run about $299–$699/month. Confirm current coverage with your insurer; details as of July 2026.